Related Experiment Video
Updated: Jun 29, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Mir-155-5p targets TP53INP1 to promote proliferative phenotype in hypersensitivity pneumonitis lung fibroblasts
Marco Espina-Ordoñez1,2, Yalbi Itzel Balderas-Martínez3, Ana Lilia Torres-Machorro4
1Laboratorio de Biopatología Pulmonar INER-Ciencias-UNAM, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, 14080, Mexico.
This study identifies a unique gene signature in hypersensitivity pneumonitis (HP) lungs and reveals miR-155-5p as a key player in the fibrotic HP fibroblast phenotype, potentially driving proliferation.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Bioinformatics
Background:
- Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that can progress to fibrosis (fHP).
- The molecular mechanisms underlying HP pathogenesis, particularly the role of microRNAs in lung fibroblasts, are not well understood.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) and microRNAs (DE-miRNAs) associated with HP lungs.
- To investigate the role of miR-155-5p in the phenotype of fibrotic HP lung fibroblasts.
Main Methods:
- Integrated bulk RNA-Seq and bioinformatic analyses to identify DEGs and DE-miRNAs.
- In vitro studies using lung fibroblasts to assess miR-155-5p expression and function.
- Loss-of-function and gain-of-function assays to determine miR-155-5p's impact on fibroblast proliferation and senescence.
Main Results:
- A unique transcriptional signature of 53 DEGs was identified in HP lungs, differentiating them from control and idiopathic pulmonary fibrosis (IPF) lungs.
- Eighteen DE-miRNAs were identified, with miR-155-5p implicated in HP pathogenesis.
- Overexpression of miR-155-5p in fHP fibroblasts correlated with reduced TP53INP1 expression, increased proliferation, and decreased senescence, effects mimicked in normal fibroblasts by miR-155-5p overexpression.
Conclusions:
- A distinct set of DEGs and DE-miRNAs, including miR-155-5p, may help differentiate HP from other fibrotic lung diseases.
- miR-155-5p upregulation and subsequent TP53INP1 downregulation in fHP fibroblasts likely contribute to their proliferative and profibrotic phenotype.
- These findings offer insights into the pathogenic mechanisms of HP and potential therapeutic targets.
More Related Videos
09:26Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
Published on: February 20, 2015
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023